(Q35247810)

7 August 2017

5 references

24 March 2019

22 April 2019

25 April 2019

19 November 2019

5 April 2021

Mild hyperphenylalaninemia: to treat or not to treat (English)

1 reference

7 August 2017

5 references

24 March 2019

22 April 2019

25 April 2019

19 November 2019

5 April 2021

1 reference

19 November 2019

1 reference

5 April 2021

Francjan J van Spronsen

series ordinal

1

1 reference

7 August 2017

publication date

24 February 2011

1 reference

Journal of Inherited Metabolic Disease

7 August 2017

1 June 2011

5 references

24 March 2019

22 April 2019

25 April 2019

19 November 2019

5 April 2021

6 references

7 August 2017

24 March 2019

22 April 2019

25 April 2019

19 November 2019

5 April 2021

34

1 reference

7 August 2017

issue

3

1 reference

7 August 2017

page(s)

651-656

1 reference

Creative Commons Attribution-NonCommercial 4.0 International

7 August 2017

copyright license

1 reference

Future treatment strategies in phenylketonuria

5 April 2021

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3183992

Psychosocial issues and outcomes in maternal PKU.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3183992

PKU-what is daily practice in various centres in Europe? Data from a questionnaire by the scientific advisory committee of the European Society of Phenylketonuria and Allied Disorders

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3183992

Total homocysteine, B-vitamins and genetic polymorphisms in patients with classical phenylketonuria.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3183992

Sustained attention in untreated non-PKU-hyperphenylalaninemia.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3183992

Impaired prenatal and postnatal growth in Dutch patients with phenylketonuria. The National PKU Steering Committee

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3183992

Hyperphenylalaninemia: diagnosis and classification of the various types of phenylalanine hydroxylase deficiency in childhood

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3183992

Nonphenylketonuric hyperphenylalaninemia.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3183992

Psychological and social findings in adolescents with phenylketonuria

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3183992

Termination of dietary treatment in phenylketonuria

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3183992

Intellectual Development and Academic Achievement of Children Treated Early for Phenylketonuria

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3183992

Stability of blood phenylalanine levels and IQ in children with phenylketonuria

27 July 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-011-9283-Y

Management of phenylketonuria in Europe: survey results from 19 countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-011-9283-Y

Neuropsychologic functions of early treated patients with phenylketonuria, on and off diet: results of a cross-national and cross-sectional study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-011-9283-Y

Evaluation of nutritional status and pathophysiology of growth retardation in patients with phenylketonuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-011-9283-Y

Cognitive functions in classic phenylketonuria and mild hyperphenylalaninaemia: experience in a paediatric population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-011-9283-Y

Neuropsychological effects of subsequent exposure to phenylalanine in adolescents and young adults with early-treated phenylketonuria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-011-9283-Y

A European multicenter study of phenylalanine hydroxylase deficiency: classification of 105 mutations and a general system for genotype-based prediction of metabolic phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-011-9283-Y

Sustained attention and inhibition of cognitive interference in treated phenylketonuria: associations with concurrent and lifetime phenylalanine concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-011-9283-Y

Motor function under lower and higher controlled processing demands in early and continuously treated phenylketonuria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-011-9283-Y

Associations between phenylalanine-to-tyrosine ratios and performance on tests of neuropsychological function in adolescents treated early and continuously for phenylketonuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-011-9283-Y

Peak bone mass in patients with phenylketonuria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-011-9283-Y

Psychiatric disorders in adult patients with early-treated phenylketonuria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-011-9283-Y

Early-treated phenylketonuria: adult neuropsychologic outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-011-9283-Y

A preliminary investigation of the role of the phenylalanine:tyrosine ratio in children with early and continuously treated phenylketonuria: toward identification of "safe" levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-011-9283-Y

Evaluation of quality of life and description of the sociodemographic state in adolescent and young adult patients with phenylketonuria (PKU).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-011-9283-Y

The truth of treating patients with phenylketonuria after childhood: the need for a new guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-011-9283-Y

Normal clinical outcome in untreated subjects with mild hyperphenylalaninemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-011-9283-Y

The intake of total protein, natural protein and protein substitute and growth of height and head circumference in Dutch infants with phenylketonuria

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3183992

Prefrontal cortex cognitive deficits in children treated early and continuously for PKU.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3183992

Plasma phenylalanine and tyrosine responses to different nutritional conditions (fasting/postprandial) in patients with phenylketonuria: effect of sample timing.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3183992

Behavior disturbance in 8-year-old children with early treated phenylketonuria

26 September 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-011-9283-Y

Effect of age at loss of dietary control on intellectual performance and behavior of children with phenylketonuria

21 January 2018

1 reference

12 December 2020

Intellectual development in 12-year-old children treated for phenylketonuria

1 reference

12 December 2020

Agoraphobia in phenylketonuria

1 reference

12 December 2020

Recommendations on the dietary management of phenylketonuria. Report of Medical Research Council Working Party on Phenylketonuria

1 reference

12 December 2020

Vitamin B12 deficiency in adolescents and young adults with phenylketonuria

1 reference

12 December 2020

Intelligence in mild atypical phenylketonuria

1 reference

12 December 2020

Growth and skeletal maturation in children with phenylketonuria

1 reference

12 December 2020

Phenylketonuria and some aspects of emotional development

1 reference

12 December 2020

Bone mineral density in patients with phenylketonuria

1 reference

12 December 2020

Neuropsychological function in mild hyperphenylalaninemia

1 reference

12 December 2020

Phenylketonuria: plasma phenylalanine responses to different distributions of the daily phenylalanine allowance over the day

1 reference

12 December 2020

Untreated non-phenylketonuric-hyperphenylalaninaemia: intellectual and neurological outcome

1 reference

12 December 2020

Factors affecting cognitive, motor, behavioral and executive functioning in children with phenylketonuria

1 reference

12 December 2020

Nutrient intake and growth of infants with phenylketonuria undergoing therapy

1 reference

12 December 2020

Vitamin B12 and vitamin B6 supplementation is needed among adults with phenylketonuria (PKU)

1 reference

12 December 2020

Persistent mild hyperphenylalaninemia in the untreated state. A prospective study

1 reference

12 December 2020

10.1007/S10545-011-9283-Y

Identifiers

DOI

1 reference

7 August 2017

1 reference

7 August 2017

1 reference